Arijit Dutta

Senior Scientist @Ionis Pharmaceuticals, Inc.

Carlsbad, CA, US
MOBILE NUMBERS
+14•••••••05

Signup · Get unlimited contacts

WORK HISTORY

Jul 2023 — Present

Senior Scientist @Ionis Pharmaceuticals, Inc.

View department →

Carlsbad, CA, US

EDUCATION

2017 — 2019

Yale School of Medicine

Postdoctoral Associate, Biochemistry and Structural Biology

2004 — 2007

The University of Burdwan

Bachelor of Science (BS), Microbiology, General

2007 — 2009

University of Calcutta

Master of Science (MS), Plant Molecular Biology

2011 — 2016

The University of Texas Medical Branch

Doctor of Philosophy (PhD), Biochemistry and Molecular Biology

SKILLS

Ingenuity Pathway AnalysisMammalian Cell CultureCancer ResearchDna RepairBaculovirusCell CultureBioinformaticsProtein PurificationCell Based AssaysMolecular GeneticsImmunofluorescenceOncologyEnzyme AssaysFluorescence SpectroscopyRecombinant Dna TechnologySmall MoleculesFlow CytometryTransfectionFplcImmunohistochemistryQpcrPcrRadiation BiologyProtein ChemistryProximity Ligation AssaySequencing GelProtein AssaysScientific WritingFluorescenceLentivirusDna ExtractionSequence AnalysisSirnaImmunoprecipitationSite-Directed MutagenesisWestern BlottingRt-PcrLife SciencesProtein ExpressionMolecular Cloning

ABOUT ARIJIT DUTTA

Senior scientist, currently working on developing novel Cas enzyme pipelines for gene-editing therapeutics, via biochemical/ structural studies and protein engineering to improve enzyme activities.• Over 13 years of research experience (academia and industry), and a track record in development of pipelines for purification, biochemical characterization and structural studies of large and challenging proteins, using bacterial and insect cell expression systems; and protein engineering. • Expertise in in-vitro reconstitution assays and enzyme kinetics for characterization of protein activities such as nucleic acid binding, unwinding, nuclease; dissecting protein-protein interactions, and biochemical mechanisms.• Executed cancer drug discovery projects: target identification, and small molecule inhibitor screening via biochemical and cell-based assays (immunofluroscence, FACS, reporter assays, viability assays, etc) to determine the mechanisms of genotoxicity and test synthetic lethality in cancer cells. • Demonstrated excellent communication skills to develop inter- and intra-organization collaborations in research. Provided mentorship to graduate and undergraduate trainees. Proven skills in scientific writing (research articles, review article, book chapters) and grant writing (3 funded).

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.